Predict your next investment

HEALTHCARE | Disease Diagnosis

See what CB Insights has to offer


Acquired Unit | Acquired



About Myriad Genetics - Autoimmune Unit

Myriad Genetics - Autoimmune Unit is a molecular diagnostic company dedicated to making a difference in patient's lives through the discovery and commercialization of transformative tests to assess a person's risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. Myriad Genetics - Autoimmune Unit includes Vectra rheumatoid arthritis (RA) assay testing solutions and technology.On May 3, 2021, Myriad Genetics - Autoimmune Unit was acquired by Labcorp at a valuation of $150M.

Myriad Genetics - Autoimmune Unit Headquarter Location

320 Wakara Way

Salt Lake City, Utah, 84108,

United States

(650) 351-1354

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.